Table 2.
The correlation between S100A14 expression and clinicopathologic characteristics in IHC analysis
| Clinical Variable | Relative expressiona of S100A14 and p-value of different categoriesb | ||
|---|---|---|---|
|
| |||
| N | Median | p-value | |
| Diagnostic category | < 0.001 | ||
| Normal | 24 | 0.37 | |
| Low grade CIN | 13 | 0.80 | |
| High grade CIN | 63 | 1.13 | |
| Cancer | 98 | 1.34 | |
| FIGO stage | 0.025 | ||
| I | 62 | 1.16 | |
| II | 26 | 1.43 | |
| III-IV | 10 | 2.13 | |
| Tumor grade | 0.698 | ||
| Well | 7 | 1.34 | |
| Moderate | 40 | 1.35 | |
| Poor | 33 | 1.48 | |
| Tumor size | 0.503 | ||
| < 4 cm | 74 | 1.235 | |
| ≥ 4 cm | 24 | 1.455 | |
| LN metastasis | 0.001 | ||
| Negative | 77 | 1.16 | |
| Positive | 21 | 1.81 | |
| Lymphovascular invasion | 0.615 | ||
| Negative | 85 | 1.34 | |
| Positive | 13 | 1.16 | |
Median of relative expression.
Mann-Whitney U and Kruskal-Wallis nonparametric test were used for comparing different groups.